Ethgen O, Terlinden A. Evaluation of risk-sharing agreements – A real option approach. To be presented as a Workshop at the 17th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Amsterdam, The Netherlands, November 8-12th, 2014. |
Schneider AG, Ethgen O, Kellum JA, Bagshaw SM, Bellomo R. Dialysis dependence after severe acute kidney injury: a health economics analysis. Podium presentation at the 31st Annual Meeting of the International Society of Blood Purification (ISBP) – Bologna, Italy, September 12-14th, 2013. |
Delbecque L, Taquet M, Ethgen O, Chassany O. When collecting patient data gets electronics: The upsurge of eHealth and the importance of BIG DATA to shape modern health care. Workshop at the 16th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Dublin, Ireland, November 2-6th, 2013. Congress Program and Schedule of Events, page 137 (W12). |
Standaert B, Ethgen O, Emerson R. Found the missing link? How to relate cohort models to observed population data. Podium presentation at the 15th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Berlin, Germany, November 3-7th, 2012. Value in Health 2012;15:A288. |
Standaert B, Ethgen O, Emerson R. Cost-effectiveness analysis – Appropriate for all situations? Podium presentation at the 17th International Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Washington DC, USA, June 2-6th, 2012. Value in Health 2012;15:A2. |
Ethgen O, O’Mahony J. Cohort, multi-cohort or population model – Why, when and how? Workshop at the 14th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Madrid, Spain, November 5-8th, 2011. Congress Program and Schedule of Events, page 120 (W23). |
Postma M, Connolly M, Ethgen O. Productivity gains – Undervalued and of increasing importance in an era of shrinking numbers of working age adults? Workshop at the 14th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Madrid, Spain, November 5-8th, 2011. Congress Program and Schedule of Events, page 119 (W18). |
Ethgen O. A risk forecasting model to help in the designing of risk-sharing schemes. 13th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Prague, Czech Republic, November 6-9th, 2010. Value in Health 2010;13:A241. |
Ethgen O, Connolly M, Postma M. Considering health as an investment rather than a cost – Alternative modelling approaches to demonstrate economic value. Workshop at the 13th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Prague, Czech Republic, November 6-9th, 2010. Congress Program and Schedule of Events, page 99 (W9). |
Ethgen O, Staginnus U. Making the most of risk-sharing schemes: Access strategies, risk analytics and tactical sharing approaches. Workshop at the 13th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Prague, Czech Republic, November 6-9th, 2010. Congress Program and Schedule of Events, page 102 (W23). |
Ethgen O. Modelling and practical approaches to risk-sharing. HTAi Policy Forum on “Handling uncertainty in HTA: International development in policy and practice, and their implications for research” at the 32nd Annual Meeting of the Society for Medical Decision Making (SMDM) – Toronto, Canada, October 24-27th, 2010. |
Ethgen O. Risk-sharing analytics: Practical and modelling approach. Parallel Panel Session on “Risk-sharing approaches and patient-access schemes: translating concept into real world settings” at the 7th Health Technology Assessment International (HTAi) Annual Meeting – Dublin, Ireland, June 6-9th, 2010 Conference Program, page 74. |
Ethgen O. Dynamic budget impact approach. Parallel Panel Session on “Health technology assessment: What additional methodologies can we offer decision makers” at the 7th Health Technology Assessment International (HTAi) Annual Meeting – Dublin, Ireland, June 6-9th, 2010 Conference Program, page 74. |
Ethgen O, Staginnus U. Designing risk-sharing schemes: Opportunities, pitfalls and preliminary modelling. Workshop at the 12th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Paris, France, October 24-27th, 2009. Congress Program and Schedule of Events, page 108 (W15). |
Ethgen O, Demarteau N, Standaert BA. Cohort modelling – Is the approach too old for the elderly? 12th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Paris, France, October 24-27th, 2009. Value in Health 2009;12:A226. |
Gao X, Snedecor S, Ethgen O, Botteman M. Impact of including cardiovascular outcomes on estimates of clinical and economic benefits of influenza vaccination in the US elderly population. 14th International Congress of the International Society for Pharmacoeconomics and Outcome Research (ISPOR) – Orlando (FL), USA, May 16-20th, 2009. Value in Health 2009;12:A13. |
Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Cost-utility of strontium ranelate in the treatment of postmenopausal women. 8th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Istanbul, Turkey, April 9-12th, 2008. Osteoporosis International 2008;19 Suppl.1:S5. |
Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Cost-effectiveness of bone densitometry screening combined with alendronate therapy for those who have osteoporosis. 10th European Congress of the International Society for Pharmacoeconomics and Outcome Research (ISPOR) – Dublin, Ireland, October 20-23rd, 2007. Value in Health 2007;10:A236. |
Ethgen O, Lamotte M, Annemans L. Health economic evaluation of bivalirudin in the management of patients undergoing percutaneous coronary intervention in Belgium. 8th European Congress of the International Society for Pharmacoeconomics and Outcome Research (ISPOR) – Florence, Italy, November 6-8th, 2005. Value in Health 2005;8:A11. |
Ethgen O, Moeremans K, Annemans L. Economic aspects of hospital malnutrition [French]. 13th Meetings of Clinical Nutrition – Durbuy, Belgium, June 2-3 2005. |
Ethgen O. The impact of osteoarthritis on quality of life [French]. Osteoarticular diseases: Multidisciplinary approach, treatments and quality of life – Department of Public Health Sciences, University of Liège – Liège, Belgium, September 11, 2003. |
Ethgen O, Fraikin G, Reginster JY. Epidemiology of osteoarthritis and osteoporosis. International Congress on Genetics of Osteoarticular Disorders – Florence, Italy, February 22-23rd, 2002. Fondazione Internationale Menarini Symposia N°162 – February 2002. |
Ethgen O, Tellier V, Ben SedrineW, De Maeseneer J, Gosset C, Reginster JY. Health-related quality of life and cost of ambulatory care in osteoporosis. May such outcome measures be valuable information to health decision makers and payers? 2nd International Meeting on Social and Economic Aspects of Osteoporosis and Bone Diseases – Liège, Belgium, December 7-9th, 2000. Osteoporosis International 2000;11 Suppl.5:S5. |
Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. Are health-related quality of life scores useful in predicting the use of health care services? Exploration in patients with arthritis. 64th American College of Rheumatology annual scientific meeting (ACR) – Philadelphia, PN, USA, November 12-16th, 2000. Arthritis and Rheumatism 2000;43 Suppl.1:S163. |